The weekly litigation news digest is live. Subscribe now

Detecting And Treating Dementia

Patent No. EP2687223 (titled "Detecting And Treating Dementia") was filed by Mayo Foundation FOR Medical Education And Research on May 30, 2007. The application was issued on Nov 20, 2024.

Patent Summary

Methods and materials for detecting and treating frontotemporal dementia (FTD) through progranulin (PGRN) gene analysis and therapy. The methods involve identifying mutations in the PGRN gene that are associated with FTD, and using nucleic acid encoding a PGRN polypeptide to treat the disease. The therapy can involve administering a PGRN polypeptide or nucleic acid to increase PGRN levels in the brain, thereby slowing or halting disease progression.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLEApr 12, 2018CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2687223

MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Application Number
EP13174869A
Filing Date
May 30, 2007
Status
Patent Maintained As Amended
Oct 18, 2024
Publication Date
Nov 20, 2024
External Links
Slate, Register, Google Patents